Target Price | $42.17 |
Price | $289.75 |
Deviation |
85.45%
register free of charge
|
Number of Estimates | 7 |
7 Analysts have issued a price target BeiGene Ltd. Sponsored ADR 2026 .
The average BeiGene Ltd. Sponsored ADR target price is $42.17.
This is
85.45%
register free of charge
$46.22
84.05%
register free of charge
$40.71
85.95%
register free of charge
|
|
A rating was issued by 14 analysts: 13 Analysts recommend BeiGene Ltd. Sponsored ADR to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the BeiGene Ltd. Sponsored ADR stock has an average upside potential 2026 of
85.45%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 3.79 | 5.12 |
56.19% | 35.14% | |
EBITDA Margin | -13.43% | 4.74% |
72.09% | 135.28% | |
Net Margin | -18.29% | 1.33% |
52.54% | 107.27% |
9 Analysts have issued a sales forecast BeiGene Ltd. Sponsored ADR 2025 . The average BeiGene Ltd. Sponsored ADR sales estimate is
This results in the following potential growth metrics:
7 BeiGene Ltd. Sponsored ADR Analysts have issued a net profit forecast 2025. The average BeiGene Ltd. Sponsored ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.51 | 0.05 |
26.09% | 109.80% | |
P/E | 5,990.46 | |
EV/Sales | 6.50 |
7 Analysts have issued a BeiGene Ltd. Sponsored ADR forecast for earnings per share. The average BeiGene Ltd. Sponsored ADR EPS is
This results in the following potential growth metrics and future valuations:
BeiGene Ltd. Sponsored ADR...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.